As a preliminary study of the clinical relevance of these miRNAs, we examined the serum levels of the respective human homolog of each Dlk1-Dio3 mat candidate NAFLD miRNA using serum samples from control, SS, or NASH patients. This evidence concerns the gene DLK1 and metabolic dysfunction-associated steatohepatitis.